This Quarterly Report on Form 10-Q contains statements that may constitute
"forward-looking statements" within the meaning of Section 27A of the Securities
Act of 1933, as amended (the "Securities Act"), and Section 21E of the
Securities Exchange Act of 1934, as amended (the "Exchange Act"), that involve
substantial risks and uncertainties. All statements contained in this Quarterly
Report on Form 10-Q other than statements of historical fact, including
statements regarding our future results of operations and financial position,
our business strategy and plans, and our objectives for future operations, are
forward-looking statements. The words "believes," "expects," "intends,"
"estimates," "projects," "anticipates," "will," "plan," "may," "should," or
similar language are intended to identify forward-looking statements.

It is routine for our internal projections and expectations to change throughout
the year, and any forward-looking statements based upon these projections or
expectations may change prior to the end of the next quarter or year. Readers of
this Quarterly Report on Form 10-Q are cautioned not to place undue reliance on
any such forward-looking statements. As a result of a number of known and
unknown risks and uncertainties, our actual results or performance may be
materially different from those expressed or implied by these forward-looking
statements. Risks and uncertainties are identified under "Risk Factors" in Item
1A herein and in our other filings with the Securities and Exchange Commission
(the "SEC"). All forward-looking statements included herein are made only as of
the date hereof. Unless otherwise required by law, we do not undertake, and
specifically disclaim, any obligation to update any forward-looking statement,
whether as a result of new information, future events, or otherwise after the
date of such statement.

You should read the following discussion and analysis of our financial condition
and results of operations together with our unaudited condensed consolidated
financial statements and related notes included elsewhere in this Quarterly
Report on Form 10-Q, and our audited consolidated financial statements and
related notes for the year ended December 31, 2021, filed with the SEC on
March 28, 2022. Unless the context otherwise requires, the terms "IonQ," "Legacy
IonQ" "we," "us," "our" and similar terms refer to IonQ Quantum, Inc. prior to
the consummation of the Business Combination and IonQ, Inc. and its wholly owned
subsidiaries after the consummation of the Business Combination. References to
"dMY" refer to the predecessor company prior to the consummation of the Business
Combination.

Overview

We are developing quantum computers designed to solve the world's most complex
problems, and transform business, society, and the planet for the better. We
believe that our proprietary technology, our architecture, and the technology
exclusively available to us through license agreements will offer us advantages
both in terms of research and development, as well as the commercial value of
our intended product offerings. We sell access to a quantum computer with 20
algorithmic qubits, and we are in the process of researching and developing
technologies for quantum computers with increasing computational capabilities.
We currently make access to our quantum computers available via three major
cloud platforms, Amazon Web Services' (AWS) Amazon Braket, Microsoft's Azure
Quantum, and Google's Cloud Marketplace, and to select customers via our own
cloud service.

We are still in the early stages of generating revenue. We have incurred
significant operating losses since our inception. Our net losses were $4.2
million for the three months ended March 31, 2022, and we expect to continue to
incur significant losses for the foreseeable future. As of March 31, 2022, we
had an accumulated deficit of $150.0 million. We expect to continue to incur
losses for the foreseeable future as we prioritize reaching the technical
milestones necessary to achieve increasingly higher number of stable qubits and
higher levels of fidelity than that which presently exists-prerequisites for
quantum computing to reach broad quantum advantage.

The Merger Agreement and Public Company Costs



On March 7, 2021, Legacy IonQ, dMY and Ion Trap Acquisition Inc. (the "Merger
Sub") entered into an Agreement and Plan of Merger (the "Merger Agreement").
Pursuant to the Merger Agreement, at the closing, the Merger Sub was merged with
and into Legacy IonQ, with Legacy IonQ continuing as the surviving corporation
following the merger, being a wholly owned subsidiary of dMY and the separate
corporate existence of the Merger Sub ceased. Commensurate with the business
combination, dMY changed its name to IonQ, Inc. and Legacy IonQ changed its name
to IonQ Quantum, Inc. IonQ became the successor registrant with the SEC, meaning
that Legacy IonQ's financial statements for previous periods will be disclosed
in the registrant's future periodic reports filed with the SEC.

While the legal acquirer in the Merger Agreement is dMY, for financial
accounting and reporting purposes under accounting principles generally accepted
in the United States of America ("U.S. GAAP"), Legacy IonQ is the accounting
acquirer and the merger is accounted for as a "reverse recapitalization" (i.e.,
a capital transaction involving the issuance of stock by dMY for the stock of
Legacy IonQ). A reverse recapitalization does not result in a new basis of
accounting, and the financial statements of the Company represent the
continuation of the financial statements of Legacy IonQ in many respects. Under
this method of accounting, dMY is treated as the "acquired" company for
financial reporting purposes.

                                       25

--------------------------------------------------------------------------------

Table of Contents



As a result of the merger, Legacy IonQ is the successor to an SEC registrant and
is listed on the New York Stock Exchange ("NYSE"), which will require IonQ to
hire additional personnel and implement procedures and processes to address
public company regulatory requirements and customary practices. As a public
company, we have incurred and expect to continue to incur, expenses for, among
other things, directors' and officers' liability insurance, director fees and
additional internal and external accounting, legal and administrative resources,
including increased audit and legal fees.

Business and Technical Highlights

• Announced a major commercial deal with Hyundai Motor Company to develop

quantum algorithms that may improve the charging, discharging, durability,


      capacity, and safety of electric vehicle batteries.


• Highlighted our collaboration with Oak Ridge National Laboratory to research

metal hydrides, which can benefit the development of technologies including


      batteries and hydrogen storage for hydrogen powered vehicles.


• Announced that the IonQ Aria system achieved a record 20 algorithmic qubits,


      representing a massive leap forward not just for IonQ.


• Announced that IonQ Aria will soon be accessible on Microsoft Azure's Quantum

Cloud, bringing the world's most powerful quantum computer out of private

beta and giving full access to the public. This will enable developers

everywhere to learn about and begin leveraging quantum and demonstrates our


      dedication to spearheading access in the industry.


• Recent results showed that IonQ's new barium qubits are already delivering on

their promise of more accurate quantum computing with a 13-fold reduction in


      state preparation and measurement errors.



  •   Secured a sustainable, perpetual source of barium qubits through a

partnership with the U.S. Department of Energy's Pacific Northwest National


      Laboratory (PNNL).


• Announced the invention of a new family of quantum gates in collaboration

with the Duke Quantum Center (DQC) at Duke University. We believe these new

gates will eventually lead to more efficient quantum algorithms requiring

many fewer qubits. Importantly, the gates can only be run using the unique


      architecture employed by IonQ and DQC systems.


• We were part of a group of private companies and universities that received a

research and development award from DARPA to fund a quantum algorithms

benchmarking project. While contracting is still being finalized, we are the


      only quantum hardware maker selected for this multi-year award.


• In May 2022, we announced that the team has completed construction on IonQ

Forte, the next generation in IonQ's series of quantum computers. Forte is a

ytterbium system that uses IonQ's in-house ion trap chip. The system

incorporates a new beam-steering technology for the lasers that control its

qubits and is designed to allow IonQ to work with larger numbers of qubits

and deliver stable beams which we believe can more precisely address and

encode those qubits. Forte is expected to launch with select developer,

partner, and research access in the second half of this year and broader


      customer access in 2023.


• Named as one of TIME's 100 Most Influential Companies, honoring IonQ in the


      "New Frontiers" category for the Company's impact across the globe.


• Hired world-class talent, with key positions filled by Laurie Babinski as

General Counsel and Secretary (Intuit's Credit Karma) and Anant Sanchetee as

Senior Director of Marketing (Meta, Dreem).

Impact of COVID-19 on Our Business



In March 2020, the COVID-19 outbreak was declared a pandemic by the World Health
Organization. There are many uncertainties regarding the ongoing pandemic, and
we are closely monitoring its impact on all aspects of our business, including
how it impacts our employees, suppliers, vendors, and business partners. The
pandemic has resulted in government authorities implementing numerous measures
to try to contain the virus, such as travel bans and restrictions, quarantines,
stay-at-home or shelter-in-place orders, and business shutdowns. These measures
may adversely impact our employees and operations and the operations of
suppliers and business partners. In addition, various aspects of our business
cannot be conducted remotely. These measures by government authorities may
continue to remain in place for a significant period of time and could adversely
affect our development plans, sales and marketing activities, and business
operations.

The evolution of the virus is unpredictable at this point and any resurgence may
slow down our ability to develop our quantum computing program. The ongoing
COVID-19 pandemic could limit the ability of suppliers and business partners to
perform, including third-party suppliers' ability to provide components and
materials. We may also experience an increase in the cost of raw materials. The
full impact of the COVID-19 pandemic continues to evolve. As such, the full
magnitude of the pandemic's effect on our financial condition, liquidity and
future results of operations is uncertain. Management continues to actively
monitor our financial condition, liquidity, operations, suppliers, industry, and
workforce.

Key Components of Results of Operations

Revenue



We have generated limited revenues since our inception. We derive revenue from
providing access to quantum-computing-as-a-service ("QCaaS") and consulting
services related to co-developing algorithms on our quantum computing systems.
In arrangements with the cloud service providers, the cloud service provider is
considered the customer and we do not have any contractual relationships with
the cloud service providers' end users.

                                       26

--------------------------------------------------------------------------------

Table of Contents



We have determined that our QCaaS contracts represent a combined, stand-ready
performance obligation to provide access to our quantum computing systems
together with related maintenance and support. The transaction price for our
contracts generally includes a variable fee based on usage of our quantum
computing systems and may include a fixed fee for a minimum volume of usage to
be made available over a defined period of access. Fixed fee arrangements may
also include a variable component whereby customers pay an amount for usage over
contractual minimums contained in the contracts. For contracts with a fixed
transaction price, the fixed fee is recognized as QCaaS subscription-based
revenues on a straight-line basis over the access period. The Company has
determined that contracts which contain consulting services related to
co-developing quantum computing algorithms and the ability to use our quantum
computing systems to run such algorithms represent a combined performance
obligation that is satisfied over-time with revenue recognized based on the
efforts incurred to date relative to the total expected effort. For contracts
without fixed fees, variable usage fees are billed and recognized during the
period of such usage.

We are currently focused on marketing our QCaaS and have entered into, and are continuing to enter into, new contracts with customers.

Operating Costs and Expenses

Cost of revenue



Cost of revenue primarily consists of expenses related to delivering our
services, including personnel-related expenses, allocated facility and other
costs for customer facing functions, and costs associated with maintaining our
in service quantum computing systems to ensure proper calibration as well as
costs incurred for maintaining the cloud on which the QCaaS resides beginning in
the period that QCaaS revenue generating activities began. Personnel-related
expenses include salaries, benefits, and stock-based compensation. Cost of
revenue excludes depreciation and amortization related to our quantum computing
systems and related software.

Research and development



Research and development expenses consist of personnel-related expenses,
including salaries, benefits and stock-based compensation, and allocated
facility and other costs for our research and development functions. Unlike a
standard computer, design and development efforts continue throughout the useful
life of our quantum computing systems to ensure proper calibration and optimal
functionality. Research and development expenses also include purchased hardware
and software costs related to quantum computing systems constructed for research
purposes that are not probable of providing future economic benefit and have no
alternate future use as well as costs associated with third-party research and
development arrangements.

Sales and marketing

Sales and marketing expenses consist of personnel-related expenses, including
salaries, benefits and stock-based compensation, costs for direct advertising,
marketing and promotional expenditures and allocated facility and other costs
for our sales and marketing functions. We expect to continue to make the
necessary sales and marketing investments to enable us to increase our market
penetration and expand our customer base.

General and administrative

General and administrative expenses consist of personnel-related expenses, including salaries, benefits and stock-based compensation, and allocated facility and other costs for our corporate, executive, finance, and other administrative functions. General and administrative expenses also include expenses for outside professional services, including legal, auditing and accounting services, recruitment expenses, information technology, travel expenses and certain non-income taxes, insurance, and other administrative expenses.



We expect our general and administrative expenses to increase for the
foreseeable future as we scale headcount with the growth of our business, and as
a result of operating as a public company, including compliance with the rules
and regulations of the SEC, NYSE, legal, audit, additional insurance expenses,
investor relations activities, and other administrative and professional
services. As a result, we expect that our general and administrative expenses
will increase in absolute dollars but may fluctuate as a percentage of total
revenue over time.

Depreciation and amortization

Depreciation and amortization expense results from depreciation and amortization of our property and equipment and intangible assets that is recognized over their estimated lives.


                                       27

--------------------------------------------------------------------------------

Table of Contents

Nonoperating Costs and Expenses

Change in fair value of warrant liabilities



The change in fair value of warrant liabilities consists of mark-to-market fair
value adjustments recorded associated with the public warrants assumed as part
of the business combination.

Other income (expense), net

Other income (expense), net consists of income earned on our money market funds and other available-for-sale investments, offset by certain other expenses.

Results of Operations



The following table sets forth our statements of operations data for each of the
periods indicated:

                                                                Three Months Ended

                                                                    March 31,
                                                              2022           2021
                                                                  (in thousands)
Revenue                                                     $   1,953      $    125
Costs and expenses:
Cost of revenue (excluding depreciation and amortization)
(1)                                                               568           181
Research and development
(1)                                                             7,338         3,654
Sales and marketing
(1)                                                             1,871           227
General and administrative
(1)                                                             9,194         2,956
Depreciation and amortization                                   1,266           445

Total operating costs and expenses                             20,237       

7,463



Loss from operations                                          (18,284 )      (7,338 )
Change in fair value of warrant liabilities                    13,448       

-


Other income (expense), net                                       609       

3



Loss before benefit for income taxes                        $  (4,227 )      (7,335 )
Benefit for income taxes                                           -             -

Net loss                                                    $  (4,227 )    $ (7,335 )

(1) Cost of revenue, research and development, sales and marketing, and general


    and administrative expenses for the periods include stock-based compensation
    expense as follows:



                               Three Months Ended
                                    March 31,
                                2022           2021
                                 (in thousands)
Cost of revenue              $       104       $  -
Research and development           1,698         454
Sales and marketing                   73          -
General and administrative         4,797         977

Comparison of the Three Months Ended March 31, 2022 and 2021



Revenue

                                                      $           %
              Three Months Ended March 31,         Change      Change
                2022                  2021
                     (in thousands)
Revenue   $          1,953         $       125     $ 1,828       1,462 %

Revenue increased by $1.8 million, or 1,462%, to $2.0 million for the three months ended March 31, 2022, from $0.1 million for the three months ended March 31, 2021. The increase was primarily driven by three new revenue contracts under which we provided services during the three months ended March 31, 2022.


                                       28

--------------------------------------------------------------------------------


  Table of Contents

Cost of revenue

                                                                                       $              %
                                             Three Months Ended March 31,            Change         Change
                                              2022                  2021
                                                    (in thousands)
Cost of revenue (excluding
depreciation and amortization)            $         568         $         181       $    387            214 %


Cost of revenue increased by $0.4 million, or 214%, to $0.6 million for the three months ended March 31, 2022, from $0.2 million for the three months ended March 31, 2021. The increase was driven by the increase in costs to service active contracts for the three months ended March 31, 2022.



Research and development

                                                                    $           %
                             Three Months Ended March 31,        Change       Change
                               2022                2021
                                    (in thousands)
Research and development   $       7,338       $       3,654     $ 3,684          101 %


Research and development expenses increased by $3.7 million, or 101%, to
$7.3 million for the three months ended March 31, 2022, from $3.7 million for
the three months ended March 31, 2021. The increase was primarily driven by a
$2.2 million increase in payroll-related expenses, including stock-based
compensation of $1.2 million as a result of increased headcount, and a $1.0
million increase in materials, supplies and equipment costs.

Sales and marketing

                                                                  $           %
                          Three Months Ended March 31,         Change       Change
                            2022                  2021
                                 (in thousands)
Sales and marketing   $          1,871         $       227     $ 1,644          724 %


Sales and marketing expenses increased by $1.6 million, or 724%, to $1.9 million
for the three months ended March 31, 2022, from $0.2 million for the three
months ended March 31, 2021. The increase was primarily due to an increase of
$1.1 million of payroll-related expenses, including an increase in stock-based
compensation of $0.1 million as a result of increased headcount, and increased
costs to promote our services and other marketing initiatives of approximately
$0.5 million.

General and administrative

                                                                      $           %
                               Three Months Ended March 31,        Change       Change
                                 2022                2021
                                      (in thousands)
General and administrative   $       9,194       $       2,956     $ 6,238          211 %


General and administrative expenses increased by $6.2 million, or 211%, to
$9.2 million for the three months ended March 31, 2022 from $3.0 million for the
three months ended March 31, 2021. The increase was primarily driven by an
increase of $4.4 million in payroll-related expenses, including an increase in
stock-based compensation of $3.8 million, primarily due to the issuance of
equity awards during the period, and an increase of $1.1 million in director and
officer insurance costs. The remaining increase is primarily due to additional
costs incurred to operate as a public company and other general and
administrative activities as a result of hiring additional personnel.

Depreciation and amortization



                                                                                         $              %
                                               Three Months Ended March 31,            Change         Change
                                                 2022                  2021
                                                      (in thousands)
Depreciation and amortization              $          1,266         $       445       $    821            184 %


Depreciation and amortization expenses increased by $0.8 million, or 184%, to
$1.3 million for the three months ended March 31, 2022, from $0.4 million for
the three months ended March 31, 2021. The increase was primarily driven by an
increase of $0.3 million due to amortization of capitalized internally developed
software and an increase of $0.4 million in depreciation expense associated with
capitalized quantum computing system costs.

                                       29

--------------------------------------------------------------------------------

Table of Contents

Change in fair value of warrant liabilities



                                                                                       $            %
                                                Three Months Ended March 31,         Change      Change
                                                     2022                 2021
                                                       (in thousands)
Change in fair value of warrant liabilities   $           13,448         $   -      $ 13,448          NM

NM-Not Meaningful


The change in fair value of warrant liabilities increased $13.5 million to $13.5
million for the three months ended March 31, 2022, from zero for the three
months ended March 31, 2021, as a result of mark-to-market income adjustments
recorded for the public warrants assumed as part of the business combination.

Other income (expense), net

                                                                       $            %
                                Three Months Ended March 31,         Change       Change
                                    2022                  2021
                                       (in thousands)
Other income (expense), net   $            609           $    3     $    606       20,200 %


Other income increased by $0.6 million, or 20,200%, to $0.6 million for the
three months ended March 31, 2022, from less than $0.1 million for the three
months ended March 31, 2021. The increase was primarily driven by an increase of
$0.8 million in interest income earned on our available-for-sale investments,
offset by other expenses of $0.2 million.

Liquidity and Capital Resources



As of March 31, 2022, we had cash and cash equivalents of $86.8 million and
available-for-sale securities of $499.7 million, with $329.2 million classified
as short-term investments and $170.5 million classified as long-term
investments. We believe that our cash, cash equivalents and investments as of
March 31, 2022, will be sufficient to meet our working capital and capital
expenditure needs for the next 12 months. We believe we will meet longer term
expected future cash requirements and obligations through a combination of cash
flows from operating activities and available funds from our cash, cash
equivalents and investment balances. However, this determination is based upon
internal projections and is subject to changes in market and business
conditions. We have incurred losses since our inception, and as of March 31,
2022, we had an accumulated deficit of $150.0 million. During the three months
ended March 31, 2022, we incurred net losses of $4.2 million. We expect to incur
additional losses and higher operating expenses for the foreseeable future.

Future Funding Requirements



We expect our principal sources of liquidity will continue to be our cash, cash
equivalents and investments and any additional capital we may obtain through
additional equity or debt financings. Our future capital requirements will
depend on many factors, including investments in growth and technology. We may,
in the future, enter into arrangements to acquire or invest in complementary
businesses, services, and technologies which may require us to seek additional
equity or debt financing.

Upon the closing of the business combination, we received approximately $636.0
million of gross proceeds. The proceeds are invested in money market funds,
commercial paper, corporate and municipal notes and bonds, and other U.S.
government and agency securities as disclosed in Note 3 in our condensed
consolidated financial statements. We expect to use these investments to fund
our strategic operations.

Our primary uses of cash are to fund our operations as we continue to grow our
business. We require a significant amount of cash for expenditures as we invest
in ongoing research and development and commercialization of our products. Until
such time as we can generate significant revenue from sales of our QCaaS, if
ever, we expect to finance our cash needs through our cash, cash equivalents and
investments, as well as equity or debt financings or other capital sources,
including potential collaborations and other similar arrangements. However, we
may be unable to raise additional funds or enter into such other arrangements
when needed on favorable terms or at all. To the extent that we raise additional
capital through the sale of equity or convertible debt securities, the ownership
interest of our stockholders will be or could be diluted, and the terms of these
securities may include liquidation or other preferences that adversely affect
the rights of our stockholders. Debt financing and equity financing, if
available, may involve agreements that include covenants limiting or restricting
our ability to take specific actions, such as incurring additional debt, making
capital expenditures, or declaring dividends. If we raise funds through
collaborations, or other similar arrangements with third parties, we may have to
relinquish valuable rights to our quantum computing technology on terms that may
not be favorable to us and/or may reduce the value of our common stock. If we
are unable to raise additional funds through equity or debt financings when
needed, we may be required to delay, limit, reduce or terminate our quantum
computing development efforts. Our future capital requirements and the adequacy
of available funds will depend on many factors, including those set forth in the
section titled "
Risk Factors
."

                                       30

--------------------------------------------------------------------------------

Table of Contents



Other than operating expenses, including our continued investment in our quantum
computers, cash requirements for the year ending December 31, 2022, are expected
to consist primarily of capital expenditures for corporate facilities.

Our material cash requirements as of March 31, 2022, include operating lease
commitments, including the lease of our headquarters in College Park, Maryland.
As of March 31, 2022, we have total operating lease obligations of $6.8 million,
with $0.7 million payable within 12 months.

Cash flows

The following table summarizes our cash flows for the period indicated:



                                                Three Months Ended March 

31,


                                                  2022                 2021
                                                       (in thousands)
Net cash used in operating activities       $         (8,324 )     $      (3,898 )
Net cash used in investing activities       $       (304,098 )     $      (2,154 )
Net cash provided by financing activities   $            148       $       

5,363

Cash flows from operating activities



Our cash flows from operating activities are significantly affected by the
growth of our business primarily related to research and development, sales and
marketing, and general and administrative activities. Our operating cash flows
are also affected by our working capital needs to support growth in
personnel-related expenditures and fluctuations in accounts payable and other
current assets and liabilities.

Net cash used in operating activities during the three months ended March 31,
2022, was $8.3 million, resulting from a net loss of $4.2 million, adjusted
for non-cash activity, primarily related to the gain recorded as a result of
mark-to-market activity for our public warrants offset by other working capital
activities. The increase in net cash used in operations from the prior year
period was primarily related to increased research and development activities,
increased compensation costs as a result of hiring personnel and increased costs
incurred as a public company.

Net cash used in operating activities during the three months ended March 31,
2021, was $3.9 million, resulting primarily from a net loss of $7.3 million,
adjusted for non-cash charges of $0.4 million in depreciation and amortization
and $1.4 million in stock-based compensation. The increase in net cash used in
operations from the prior year was primarily related to our increased research
and development activities and associated hiring of personnel, partially offset
by an increase in accrued expenses primarily driven by legal fees related to the
merger with dMY.

Cash flows from investing activities



Net cash used in investing activities during the three months ended March 31,
2022, was $304.1 million, primarily resulting from purchases of
available-for-sale investments of $311.2 million, additions of $2.7 million to
property and equipment related to the development of our quantum computing
systems, offset by cash received from maturities of available-for-sale
investments of $10.4 million.

Net cash used in investing activities during the three months ended March 31,
2021, was $2.2 million, primarily resulting from additions of $1.7 million to
property and equipment primarily related to the development of our quantum
computing systems, $0.3 million of capitalized internal software development
costs, and $0.2 million of intangible assets acquisition costs.

Cash flows from financing activities

Net cash provided by financing activities during the three months ended March 31, 2022, was $0.1 million, primarily resulting from proceeds from stock options exercised.

Net cash provided by financing activities during the three months ended March 31, 2021, was $5.4 million, primarily resulting from proceeds from stock options exercised.



                                       31

--------------------------------------------------------------------------------

Table of Contents

Critical Accounting Estimates



This discussion and analysis of financial condition and results of operations is
based upon the Company's condensed consolidated financial statements, which have
been prepared in accordance with U.S. GAAP. The preparation of these financial
statements requires us to make estimates and assumptions that affect the
reported amounts of assets and liabilities and the disclosure of contingent
assets and liabilities. We also make estimates and assumptions on revenue
generated and reported expenses incurred during the reporting periods. Our
estimates are based on our historical experience and on various other factors
that we believe are reasonable under the circumstances. The results of these
estimates form the basis for making judgments about the carrying value of assets
and liabilities that are not readily apparent from other sources. Actual results
may differ from these estimates.

There have been no material changes to our critical accounting estimates from those described under "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our Annual Report.



Critical accounting estimates are defined as those reflective of significant
judgments, estimates and uncertainties, which may result in materially different
results under different assumptions and conditions. Within our Annual Report, we
have disclosed our critical accounting estimates that we believe to have the
greatest potential impact on our consolidated financial statements.
Historically, our assumptions, judgments and estimates relative to our critical
accounting estimates have not differed materially from actual results.

                                       32

--------------------------------------------------------------------------------

Table of Contents

Recently Issued and Adopted Accounting Standards

See Note 2, Summary of Significant Accounting Policies, in the notes to our condensed consolidated financial statements included in Part I, Item I of this Quarterly Report on Form 10-Q for a discussion of recent accounting pronouncements.

© Edgar Online, source Glimpses